Avista to invest in safety testing company

The $210m investment in BioReliance Corporation follows two other Avista investments in the healthcare industry in 2006.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this